We tested the requirement of gut hormone receptors GLP-1R, GIPR, and GLP-2R using double receptor knockout mice to account for overlapping and compensatory roles of gut hormone action
Per a 2019 article in the Annals of Allergy, Asthma, & Immunology, it is difficult to quantify exactly how many people develop allergies to monoclonal antibodies, mostly because there are many different types, each unique in composition
Zepbound, or tirzepatide in general, while operating under the same mechanism as other GLP-1 drugs, may exhibit subtle differences in its onset of effects due to its formulation
In a normal patient, PIH risk is manageable and largely predictable based on Fitzpatrick skin type and careful parameter selection
Proc Natl Acad Sci USA 85:66226626
PMID: 29634344